Revolutionising pharmaceutical processes such as drug discovery and repurposing with computational algorithms, require the successful pairing of experienced medical research and technology development capabilities. Smart Pharma is a joint force collaboration between Aptorum Group and Aenco Solutions, which together amalgamates decades of combined expertise across highly specialised capabilities including clinical research, drug formulation, blockchain application development, big-data analytics, and more.

Smart Pharma Group

We are an experienced team of scientists, researchers, and technologists, taking intrepid steps in transforming the global drug discovery effort and its development pathway. Through our in-house developed Smart-ACTTM program we believe we are revolutionizing the drug repurposing and repositioning industries; with a particular focus in servicing orphan diseases and unmet medical needs. With invaluable resource support from our ultimate parent company, Aptorum Group Limited (Nasdaq: APM), collaborated with Aenco Solutions, a Blockchain-based company (token ticker: AEN) , we are securing a perpetual pipeline for the generation of impactful drug candidates and therapeutic innovation into the future!

Aptorum Group

Aptorum Group Limited (Nasdaq: APM) (www.aptorumgroup.com), the ultimate parent company of the Smart Pharma Group, is a pharmaceutical company dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. Aptorum Group is pursuing therapeutic and diagnostic projects in neurology, infectious diseases, gastroenterology, oncology and other disease areas as well as non-therapeutic areas such as surgical robotics and the operations of its medical clinic in Hong Kong, Talem Medical, with the initial focus on treatment of chronic diseases resulting from modern sedentary lifestyles and aging population.

The SMPT token is not registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”). The SMPT tokens may not be offered for sale, sold or otherwise transferred, either directly or indirectly in the U.S. or to U.S. persons except in accordance with Regulation S promulgated under the Securities Act, pursuant to an effective registration statement under the securities act or pursuant to an exemption from registration under the securities act If you are not sure whether you are eligible to purchase the SMPT token or have any inquiries, please sign up for our Whitelist or email us at [email protected]